Mycoplasma Testing Market Research Report - Global Forecast till 2027

Global Mycoplasma Testing Market Research Report: By Product (Kits & Reagents, Instruments, Services), by Technique (DNA, PCR, ELISA, Direct, Indirect Assay), by Application (cell line testing, virus testing), by end user (CRO, Cell banks)—Forecast till 2027

ID: MRFR/LS/5312-HCR | February 2021 | Region: Global | 100 pages

Please note that the assessment period of report has been updated from 2018–2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario:


Global mycoplasma testing market is expected to grow significantly over the forecast period. It is anticipated that the market held a market value of USD 514 million in 2017 and is projected to grow at a CAGR of 11.6% over the forecast period. Mycoplasma testing used to detect contamination in given biologic sample.


The factors such as Increasing R&D expense and new product launches are expected to propel the growth of the market. However, available of alternative traditional method hamper the market growth over the forecast period.


Key players:


Charles River Laboratories, Inc., Merck KGaA, Lonza Group Ltd, Roche Diagnostics, SGS S.A., American Type Culture Collection, Invivogen, Wuxi Apptec, Thermo Fisher Scientific Inc., Promocell GmbH are some of the key players in the global mycoplasma testing market.
Intended Audience



  • Mycoplasma testing products Manufacturers and vendors

  • Mycoplasma testing service providers

  • Pharmaceutical and Biotech companies

  • Contract research organization

  • Various research and consulting firms


Market Segmentation:


The global mycoplasma testing market has been segmented into product, Technique, and application.


Based on product, market segmented into kits & reagents, instruments, and services. The kits & reagents segment is expected to account for the largest share segment of the market in 2017.


Based on Technique, market segmented into DNA Stain, Enzyme-based, PCR, ELISA, Direct Assay, Indirect Assay, Others.


Based on application, market segmented into cell line and cell therapy testing, virus testing, row material testing, lot release testing, and others.


Based on end user, market segmented into pharmaceutical and biological manufacturing, contract research organizations, cell banks, and others.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The mycoplasma testing market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European mycoplasma testing market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.


The mycoplasma testing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The mycoplasma testing market in the Middle East & Africa has been segmented into the Middle East and Africa.


Global Mycoplasma Testing Market Share (%), by Region, 2017


Source: Annual Reports and Sec filings


Regional Market Summary


Geographically, the Americas is anticipated to dominate the global mycoplasma testing market owing to a well-established player and increasing R&D expenses.


Europe is expected to hold the second largest position in the global mycoplasma testing market. The market growth in this region is attributed to the growth in pharmaceutical and medical device industry.


The mycoplasma testing market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the increasing adoption of these products.


The Middle East & Africa has the least share of the market.


Global Mycoplasma Testing Market, by Product



  • Kits & Reagents

  • Instruments

  • Services


Global Mycoplasma Testing Market, by Technique



  • DNA Stain

  • Enzyme-based

  • PCR

  • ELISA

  • Direct Assay

  • Indirect Assay

  • Others


Global Mycoplasma Testing Market, by Application



  • Cell Line and Cell Therapy Testing

  • Virus Testing

  • Row Material Testing

  • Lot Release Testing

  • Others


Global Mycoplasma Testing Market, by End User



  • Pharmaceutical and Biological Manufacturing

  • Contract Research Organizations

  • Cell Banks

  • Others


Global Mycoplasma Testing Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • South America



  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe



  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Middle East & Africa

    • Middle East

    • Africa




The report for Global Mycoplasma Testing Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.



Frequently Asked Questions (FAQ) :


The mycoplasma testing market is projected to grow at an 11.6% CAGR between 2018-2023.

The Americas is projected to command the largest share in the mycoplasma testing market.

It is widely used in lot release testing, virus testing, and others.

New product launches and increasing R&D expenditure is adding market growth.

Availability of alternatives may limit market growth.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

Chapter 6. Global Mycoplasma Testing Market, by Product

6.1 Introduction

6.2 Kits & Reagents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Instruments

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Services

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Mycoplasma Testing Market, by Technology

7.1 Introduction

7.2 DNA Stain

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Enzyme-based

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 PCR

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 ELISA

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.6 Direct Assay

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.7 Direct Assay

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.8 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Mycoplasma Testing Market, by Application

8.1 Introduction

8.2 Cell Line and Cell Therapy Testing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Virus Testing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Row Material Testing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.5 Lot Material Testing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.6 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Mycoplasma Testing Market, by End User

9.1 Introduction

9.2 Pharmaceutical and Biological Manufacturing

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.3 Contract Research Organizations

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.4 Cell Banks

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9.5 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 10. Global Mycoplasma Testing Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 Charles River Laboratories, Inc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Merck KGaA

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Lonza Group Ltd

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Roche Diagnostics

12.4.1 Company Overview

12.4.2 Product Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 SGS S.A.

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 American Type Culture Collection

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Invivogen

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Wuxi Apptec

12.8.1 Overview

12.8.2 Product Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Promocell GmbH

12.9.1 Overview

12.9.2 Product Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Thermo Fisher Scientific Inc.

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Mycoplasma Testing Industry

Chapter 14. Appendix


LIST OF TABLES

Table 1 Global Mycoplasma Testing Market Synopsis, 2020-2027

Table 2 Global Mycoplasma Testing Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Mycoplasma Testing Market, by Region, 2020-2027 (USD Million)

Table 4 Global Mycoplasma Testing Market, by Product, 2020-2027 (USD Million)

Table 5 Global Mycoplasma Testing Market, by Technique, 2020-2027 (USD Million)

Table 6 Global Mycoplasma Testing Market, by Application, 2020-2027 (USD Million)

Table 7 Global Mycoplasma Testing Market, by End User, 2020-2027 (USD Million)

Table 8 North America: Mycoplasma Testing Market, by Product, 2020-2027 (USD Million)

Table 9 North America: Mycoplasma Testing Market, by Technique, 2020-2027 (USD Million)

Table 10 North America: Mycoplasma Testing Market, by Application, 2020-2027 (USD Million)

Table 11 North America: Mycoplasma Testing Market, by End User, 2020-2027 (USD Million)

Table 12 US: Mycoplasma Testing Market, by Product, 2020-2027 (USD Million)

Table 13 US: Mycoplasma Testing Market, by Technique, 2020-2027 (USD Million)

Table 14 US: Mycoplasma Testing Market, by Application, 2020-2027 (USD Million)

Table 15 US: Mycoplasma Testing Market, by End User, 2020-2027 (USD Million)

Table 16 Canada: Mycoplasma Testing Market,by Product, 2020-2027 (USD Million)

Table 17 Canada: Mycoplasma Testing Market,by Technique, 2020-2027 (USD Million)

Table 18 Canada: Mycoplasma Testing Market, by Application, 2020-2027 (USD Million)

Table 19 Canada: Mycoplasma Testing Market, by End User, 2020-2027 (USD Million)

Table 20 South America: Mycoplasma Testing Market, by Product, 2020-2027 (USD Million)

Table 21 South America: Mycoplasma Testing Market, by Technique, 2020-2027 (USD Million)

Table 22 South America: Mycoplasma Testing Market, by Application, 2020-2027 (USD Million)

Table 23 South America: Mycoplasma Testing Market, by End User, 2020-2027 (USD Million)

Table 24 Europe: Mycoplasma Testing Market, by Product, 2020-2027 (USD Million)

Table 25 Europe: Mycoplasma Testing Market, by Technique, 2020-2027 (USD Million)

Table 26 Europe: Mycoplasma Testing Market, by Application, 2020-2027 (USD Million)

Table 27 Europe: Mycoplasma Testing Market, by End User, 2020-2027 (USD Million)

Table 28 Western Europe: Mycoplasma Testing Market, by Product, 2020-2027 (USD Million)

Table 29 Western Europe: Mycoplasma Testing Market, by Technique, 2020-2027

(USD Million)

Table 30 Western Europe: Mycoplasma Testing Market, by Application, 2020-2027 (USD Million)

Table 31 Western Europe: Mycoplasma Testing Market, by End User, 2020-2027 (USD Million)

Table 32 Eastern Europe: Mycoplasma Testing Market, by Product, 2020-2027 (USD Million)

Table 33 Eastern Europe: Mycoplasma Testing Market, by Technique, 2020-2027 (USD Million)

Table 34 Eastern Europe: Mycoplasma Testing Market, by Application, 2020-2027 (USD Million)

Table 35 Eastern Europe: Mycoplasma Testing Market, by End User, 2020-2027 (USD Million)

Table 36 Asia-Pacific: Mycoplasma Testing Market, by Product, 2020-2027 (USD Million)

Table 37 Asia-Pacific: Mycoplasma Testing Market, by Technique, 2020-2027 (USD Million)

Table 38 Asia-Pacific: Mycoplasma Testing Market, by Application, 2020-2027 (USD Million)

Table 39 Asia-Pacific: Mycoplasma Testing Market, by End User, 2020-2027 (USD Million)

Table 40 Middle East & Africa: Mycoplasma Testing Market, by Product, 2020-2027

(USD Million)

Table 41 Middle East & Africa: Mycoplasma Testing Market, by Technique, 2020-2027

(USD Million)

Table 42 Middle East & Africa: Mycoplasma Testing Market, by Application, 2020–

2027 (USD Million)

Table 43 Middle East & Africa: Mycoplasma Testing Market, by End User, 2020–

2027 (USD Million)


LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Mycoplasma Testing Market

Figure 3 Segmentation Market Dynamics for Global Mycoplasma Testing Market

Figure 4 Global Mycoplasma Testing Market Share, by Product, 2020

Figure 5 Global Mycoplasma Testing Market Share, by Technique, 2020

Figure 6 Global Mycoplasma Testing Market Share, by Application, 2020

Figure 7 Global Mycoplasma Testing Market Share, by End User, 2020

Figure 8 Global Mycoplasma Testing Market Share, by Region, 2020

Figure 9 North America: Mycoplasma Testing Market Share, by Country, 2020

Figure 10 Europe: Mycoplasma Testing Market Share, by Country, 2020

Figure 11 Asia-Pacific: Mycoplasma Testing Market Share, by Country, 2020

Figure 12 Middle East & Africa: Mycoplasma Testing Market Share, by Country, 2020

Figure 13 Global Mycoplasma Testing Market: Company Share Analysis, 2020 (%)

Figure 14 Charles River Laboratories, Inc : Key Financials

Figure 15 Charles River Laboratories, Inc : Segmental Revenue

Figure 16 Charles River Laboratories, Inc : Geographical Revenue

Figure 17 Merck KGaA: Key Financials

Figure 18 Merck KGaA: Segmental Revenue

Figure 19 Merck KGaA: Geographical Revenue

Figure 20 Lonza Group Ltd: Key Financials

Figure 21 Lonza Group Ltd: Segmental Revenue

Figure 22 Lonza Group Ltd: Geographical Revenue

Figure 23 Roche Diagnostics: Key Financials

Figure 24 Roche Diagnostics: Segmental Revenue

Figure 25 Roche Diagnostics: Geographical Revenue

Figure 26 SGS S.A.: Key Financials

Figure 27 SGS S.A.: Segmental Revenue

Figure 28 SGS S.A.. Geographical Revenue

Figure 29 American Type Culture Collection: Key Financials

Figure 30 American Type Culture Collection: Segmental Revenue

Figure 31 American Type Culture Collection: Geographical Revenue

Figure 32 Invivogen: Key Financials

Figure 33 Invivogen: Segmental Revenue

Figure 34 Invivogen: Geographical Revenue

Figure 35 Wuxi Apptec: Key Financials

Figure 36 Wuxi Apptec: Segmental Revenue

Figure 37 Wuxi Apptec: Geographical Revenue

Figure 38 Thermo Fisher Scientific Inc: Key Financials

Figure 39 Thermo Fisher Scientific Inc: Segmental Revenue

Figure 40 Thermo Fisher Scientific Inc: Geographical Revenue

Figure 41 Promocell GmbH: Key Financials

Figure 42 Promocell GmbH: Segmental Revenue

Figure 43 Promocell GmbH: Geographical Revenue